期刊文献+

miR-504在原发性肝细胞癌中的表达及其临床意义 被引量:2

Expression and Clinical Significance of miR-504 in Primary Hepatocellular Carcinoma
下载PDF
导出
摘要 背景:microRNA表达失调与肿瘤的形成相关。miR-504在多种肿瘤中表达,但在肝癌中的表达目前尚未见相关报道。目的:探讨miR-504在原发性肝细胞癌(HCC)和肝癌细胞株中的表达及其与预后的关系。方法:收集85例HCC患者手术标本,常规培养5株肝癌细胞株和永生化肝细胞株。以CCK8法检测miR-504表达对HepG 2细胞增殖的影响,实时荧光定量PCR法检测miR-504表达,分析miR-504表达与HCC患者临床病理特征和预后的关系。结果:与正常肝细胞相比,5种肝癌细胞中miR-504表达显著降低(P<0.05)。上调miR-504表达明显抑制HepG 2细胞增殖,而下调miR-504表达则促进细胞增殖。HCC患者miR-504表达显著低于相应癌旁组织,且与肿瘤分化程度(P=0.002)、TNM分期(P=0.021)、甲胎蛋白(P=0.012)和门静脉癌栓(P=0.003)密切相关,但与患者的性别、年龄、肿瘤大小、肿瘤数量无关。miR-504低表达者的生存时间较高表达者明显缩短(P<0.05)。结论:miR-504在HCC中表达下调,其表达与患者的临床预后相关,提示miR-504可作为判断HCC患者预后的独立预测因子。 Background: Dysregulation of microRNA expression is involved in the carcinogenesis of many tumors,expression of miR-504 has been observed in many tumors,but its expression in primary hepatocellular carcinoma( HCC) has not been reported. Aims: To explore the expression and clinical significance of miR-504 in HCC tissues and cells. Methods:Tumor and para-cancerous tissue in 85 HCC patients were collected. Five liver cancer cell lines and immortalized liver cell line were conventionally cultured. Effect of miR-504 expression on HepG 2 cells proliferation was determined by CCK8 assay. The expression of miR-504 was determined by real time fluorescent quantitative PCR. Relationships between expression of miR-504 and clinicopathological features and prognosis of HCC patients were analyzed. Results: Compared with normal liver cells,expression of miR-504 was significantly downregulated in five liver cancer cells( P < 0. 05). Upregulation of miR-504 inhibited proliferation of HepG 2 cells,and down-regulation of miR-504 promoted proliferation of HepG 2 cells. miR-504 expression in tumor tissue was significantly decreased than that in corresponding para-cancerous tissue. Expression of miR-504 was correlated with tumor differentiation( P = 0. 002),TNM stage( P = 0. 021),alpha fetoprotein( P = 0. 012) and portal vein tumor thrombus( P = 0. 003),but not with gender,age,tumor size and tumor number. Survival in HCC patients with lower miR-504 expression was significantly shorter than that in patients with high expression( P < 0. 05). Conclusions: Expression of miR-504 is downregulated in HCC,and is correlated with the prognosis of patients,suggesting that miR-504 can be used as an independent predictor for prognosis of HCC patients.
出处 《胃肠病学》 2016年第4期202-205,共4页 Chinese Journal of Gastroenterology
关键词 肝细胞 miR-504 细胞增殖 预后 Carcinoma,Hepatocellular miR-504 Cell Proliferation Prognosis
  • 相关文献

参考文献13

  • 1Orellana EA,Kasinski AL.MicroRNAs in cancer:a historical perspective on the path from discovery to therapy. Cancers (Basel) . 2015
  • 2Notari M,Pulecio J,Raya.Update on the pathogenic implications and clinical potential of microRNAs in cardiac disease. Biomed Res Int . 2015
  • 3M-H Yang,B-R Lin,C-H Chang,S-T Chen,S-K Lin,M Y-P Kuo,Y-M Jeng,M-L Kuo,C-C Chang.Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncegene . 2011
  • 4Kumar M,Lu Z,Takwi A A L,Chen W,Callander N S,Ramos K S,Young K H,Li Y.Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncegene . 2010
  • 5Zhao L,Tang M,Hu Z,et al.miR-504 mediated downregulation of nuclear respiratory factor 1 leads to radioresistance in nasopharyngeal carcinoma. Oncotarget . 2015
  • 6Yang Song,Fei Wang,Qi Huang,Yan Cao,Yingying Zhao,Changqing Yang.??MicroRNAs Contribute to Hepatocellular Carcinoma(J)Mini-Reviews in Medicinal Chemistry . 2015 (6)
  • 7Callegari E,Gramantieri L,Domenicali M,et al.Micro RNAs in liver cancer:a model for investigating pathogenesis and novel therapeutic approaches. Cell Death and Differentiation . 2015
  • 8Wenwei Hu,Chang S. Chan,Rui Wu,Cen Zhang,Yvonne Sun,Jun S. Song,Laura H. Tang,Arnold J. Levine,Zhaohui Feng.??Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504(J)Molecular Cell . 2010 (5)
  • 9Xie KL,Zhang YG,Liu J,et al.MicroRNAs associated with HBV infection and HBV-related HCC. Theranostics . 2014
  • 10Iván Lyra-González,Laura E Flores-Fong,Ignacio González-García,David Medina-Preciado,Juan Armendáriz-Borunda.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine[J].World Journal of Hepatology,2015,7(11):1530-1540. 被引量:10

二级参考文献227

  • 1Heavey PM, McKenna D, Rowland IR. Colorectal cancerand the relationship between genes and the environment. NutrCancer 2004; 48: 124-141 [PMID: 15231447 DOI: 10.1207/s15327914nc4802_2].
  • 2Terzi-J, Grivennikov S, Karin E, Karin M. Inflammation andcolon cancer. Gastroenterology 2010; 138: 2101-2114.e5 [PMID:20420949 DOI: 10.1053/j.gastro.2010.01.058].
  • 3Schetter AJ, Harris CC. Alterations of microRNAs contribute tocolon carcinogenesis. Semin Oncol 2011; 38: 734-742 [PMID:22082759 DOI: 10.1053/j.seminoncol.2011.08.009].
  • 4Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E,Norat T. Red and processed meat and colorectal cancer incidence:meta-analysis of prospective studies. PLoS One 2011; 6: e20456[PMID: 21674008 DOI: 10.1371/journal.pone.0020456].
  • 5Doubeni CA, Laiyemo AO, Major JM, Schootman M, Lian M,Park Y, Graubard BI, Hollenbeck AR, Sinha R. Socioeconomicstatus and the risk of colorectal cancer: an analysis of more than ahalf million adults in the National Institutes of Health-AARP Dietand Health Study. Cancer 2012; 118: 3636-3644 [PMID: 22898918DOI: 10.1002/cncr.26677].
  • 6Hravec S, Glava-D. MicroRNAs as Novel Biomarkers inColorectal Cancer. Front Genet 2012; 3: 180 [PMID: 23091478].
  • 7American Cancer Society. Colorectal Cancer Facts & Figures2011-2013. Atlanta: American Cancer Society, 2011. Availablefrom: URL: http://www.cancer.org/research/cancerfactsfigures/colorectalcancerfactsfigures/colorectal-cancer-facts-figures-2011-2013-page.
  • 8American Cancer Society. Cancer Facts & Figures 2012. Atlanta:American Cancer Society; 2012. Available from: URL: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/.
  • 9Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, PanJ, Galandiuk S. Plasma miR-21: a potential diagnostic marker ofcolorectal cancer. Ann Surg 2012; 256: 544-551 [PMID: 22868372DOI: 10.1097/SLA.0b013e318265bd6f].
  • 10American Cancer Society. Cancer Facts and Figures, 2010.American Cancer Society. Accessed April 13, 2014. Availablefrom: URL: http://www.cancer.org/Research/CancerFactsFigures/index.

共引文献28

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部